I Holland to share the science behind tool maintenance

9 Jul 2019

Proper maintenance - rather than replacement - of compression tooling will improve profitability.

I Holland will once again share its knowledge with tablet compression manufacturers by hosting a free webinar which investigates the science behind professional punch and die maintenance, and how it will improve profitability.

I Holland to share the science behind tool maintenance

The webinar, to be held on 15 August, will examine the challenges of tool maintenance and the science behind it. It will follow I Holland's PharmaCare 7 Step Process, a logical, professional approach to tooling maintenance and storage which has already been adopted by many companies around the world as a Standard Operating Procedure.

“Tooling maintenance is internationally recognised by manufacturers and customers around the world to be a necessity,” explains Marianna D’Onghia, I Holland marketing co-ordinator. “The reason behind it is simple. Compression tooling should not be viewed simply as consumable items that are easily replaced. Instead, we argue that if you take care and follow proper maintenance and management procedures, your tooling will last longer. The result is less tablet press downtime and a significant return on investment from not having to replace your tools constantly.”

The webinar will detail each of the 7 steps and explain the options available in the marketplace, the recommended method and the science behind the method.

“This free web presentation will aim to teach you the how and the why,” continued Marianna. “The webinar concentrates on four main areas. Understanding the reasons why we recommend that you carry out each of the steps; a thorough review of equipment options available in the marketplace to carry out each step; the preferred method and its associated benefits; and finally the science behind both the step and the preferred method. We will answer the question why each of the steps is important, really exploring the science behind maintenance techniques and getting into the finer details and scientific facts.

“Implementing a planned, professional maintenance process is key to getting the best from your tooling and ultimately helping to improve profitability in tablet production. We hope those that sign up to the free webinar will leave the educational session feeling more knowledgeable about the importance of proper tool maintenance.”

This webinar will explain why correct tooling maintenance is critical in order to obtain the maximum life from punches and dies. Re-emphasizing that the application of a structured maintenance process results in the direct impact on the reduction of many common tablet and tooling problems. By adopting these recommended ‘best practices’ tablet manufacturers will ensure the maximum life from tablet tooling is achieved, an increase in production and direct cost savings.

Read More

Related news

Colorcon launches new $50 million VC Fund

Colorcon launches new $50 million VC Fund

17 Sep 2019

The fund will target investments in transformational solutions across manufacturing, supply chain, and delivery of pharmaceutical products and services.

Read more 
M2i Life Sciences completes a historic fundraising of 60 million Euros

M2i Life Sciences completes a historic fundraising of 60 million Euros

16 Sep 2019

To support its strong growth, M2i Life Sciences has concluded a capital increase of 60 million Euros with five leading investors (ADM Capital, Eurazeo Growth, Téthys Invest, Creadev and France 2i fund managed by RAISE Impact).

Read more 
Daiichi Sankyo releases new generic formulation for sustained cancer pain treatment

Daiichi Sankyo releases new generic formulation for sustained cancer pain treatment

13 Sep 2019

New formulation of oxycodone hydrochloride contains the narcotic antagonist naloxone in order to prevent abuse.

Read more 
Mallinckrodt to sell BioVectra for $250 million

Mallinckrodt to sell BioVectra for $250 million

11 Sep 2019

Transaction continues to advance Mallinckrodt's strategic focus on branded, high-growth biopharmaceuticals by monetizing a non-core business.

Read more 
Thermo Fisher Scientific signs agreement with Lilly Oncology for companion diagnostic

Thermo Fisher Scientific signs agreement with Lilly Oncology for companion diagnostic

10 Sep 2019

Strategic agreement utilizes FDA-approved next-generation sequencing Oncomine Dx Target Test to identify RET-altered NSCLC and thyroid cancer patients who may be suitable for Lilly's RET inhibitor.

Read more 
FUJIFILM Irvine Scientific launches BalanCD Gal Supplement for biotherapeutic development

FUJIFILM Irvine Scientific launches BalanCD Gal Supplement for biotherapeutic development

10 Sep 2019

Delivers enhanced galactosylation for improved protein quality, and antibody binding and function.

Read more 
Drivers behind Saudi Arabia’s forecast 10.74 $billion 2022 market

Drivers behind Saudi Arabia’s forecast 10.74 $billion 2022 market

9 Sep 2019

Growing population, increase in non-communicable diseases and major investment in new hospitals, clinics and treatments driving growth.

Read more 
Catalent to open new clinical supply facility in San Diego

Catalent to open new clinical supply facility in San Diego

6 Sep 2019

Will enhance speed to clinic through expanded early-phase clinical supply and oral dose development services.

Read more 
Take part in pharma’s largest reputation survey

Take part in pharma’s largest reputation survey

6 Sep 2019

Use your voice to shape CPhI Worldwide's third annual global survey of the major trends, changes and developments in the industry.

Read more 
BioCity backs world's first Rx to OTC switch incubator

BioCity backs world's first Rx to OTC switch incubator

5 Sep 2019

Maxwellia considered to have the skills and the expertise to deliver and reach their goal of creating the big OTC brands of the future.

Read more